Nomura Asset Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1598 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 1617 |
|
|
2024
Q4 | – | Sell |
-65,033
| Closed | -$1.89M | – | 1560 |
|
|
2024
Q3 | $1.89M | Buy |
+65,033
| New | +$1.89M | 0.01% | 738 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1577 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1590 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1607 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1617 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1619 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1609 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1575 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1594 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1604 |
|
|
2022
Q1 | – | Sell |
-10,402
| Closed | -$464K | – | 1614 |
|
|
2021
Q4 | $464K | Buy |
+10,402
| New | +$464K | ﹤0.01% | 910 |
|
|
2021
Q3 | – | Sell |
-7,210
| Closed | -$566K | – | 1058 |
|
|
2021
Q2 | $566K | Hold |
7,210
| – | – | ﹤0.01% | 903 |
|
|
2021
Q1 | $412K | Buy |
+7,210
| New | +$412K | ﹤0.01% | 903 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1039 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 973 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 990 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 959 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 999 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1025 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1005 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 961 |
|